Hello misiu143, I ended my last post to you with this

New Post Public Reply Private Reply Replies (1) Message Board
blafarm misiu143 #20067
477
Hello misiu143,

I ended my last post to you with this paragraph: (https://investorshangout.com/post/view?id=5692895)

Quote:
I believe I have adequately addressed your questions. It does make me sad to recognize that your curious line of inquiry has the trappings of someone who thinks that I am here specifically to spread negative information for financial gain. Allow me to disabuse you of that notion. I do not short this stock. I am long and strong, that is, until such time that the investment thesis is disproved. There's nothing more I can write that will dissuade you from that incorrect characterization.


I recognize that you might not be a native English speaker ... forgive me if I am mistaken. However, on the basis that assumption is true, it would be appropriate to extend to you the benefit of doubt that your follow-up comments and questions are sincere and not designed to insult or disparage me. And on that basis, and because I would very much like to have a friendly and productive discourse with you going forward, I will attempt to address your comments and questions one more time.

Quote:
I read your post , nothing much really positive in it


What exactly are you looking for? I think most board members would agree that my post was honest, straightforward, and forthright. If you are looking for a blind cheerleader who indiscriminately sugar coats everything -- I am not your person. I am a "eyes wide open" individual, and I try to understand opportunity and risk from a variety of perspectives.

Quote:
but then you are saying that you are long... still don't know why ??


Really? If you are being honest, then I can only imagine that you somehow did not fully read my post. I will once again provide my response to that question:

Quote:
Simply put -- I want to believe. I want to believe that a single drug can miraculously address this amazing plurality of diseases. I want to believe that millions of people suffering from these diseases can maybe have the opportunity to live long, healthy, and productive lives. I want to believe that the families and friends of those inflicted will have their loved ones in their lives for many years to come. And, in the interest of full disclosure, I sure wouldn't mind a financial benefit from my support of the company relating to my investment.


If you still don't understand why I am long -- there is nothing more I can say.

Quote:
Even the one thing about coronavirus , not being in medical research , why would you say...

" discounting COVID-19 , as is complete unproven "

I listen to Dr Patterson , and try to read a lot , and in contrary I believe there is a good chance , it might work to prevent death


Let's take a step back and take a hard look at what you are saying. You have just asserted that "there is a good chance " and "it might work". I am saying that from a stock valuation point-of-view, I would not include the value of a COVID-19 indication in the stock price because it is, as of yet, untested and unproven (at least as far as I am aware).

It would be just plain silly for someone to argue that CYDY was worth more money due to leronlimab working against that virus -- at a time when it had not yet even been tested against that virus. Who would do that?

But more importantly, I would like to point out that there is actually no tension (legal term) between the language we are both using to describe this potential indication. You are saying it has "good chance" and "it might work" -- and I am saying it is too early to add the value of that potential indication to the stock price. I don't quite understand why you are repeatedly taking me to task for a statement that is fundamentally identical to your comment.

And yes, were I to contract COVID-19, I would be calling Dr. NP and asking for injections too.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

ketteQ Raises $20M to Propel AI-Driven Supply Chain Solutions

Updated Category News Views 173

ketteQ Secures Significant Funding for Global Advancement Funding round supports ketteQ's mission to deliver adaptive planning, AI-powered insights, and measurable results in months, not years. ketteQ, a leader in adaptive supply chain planning solutions, has successfully raised $20 million in Series B funding, spearheaded by Vocap Partners. This fresh funding is set to...

Continue Reading
Cathie Wood's ARK Funds Make Strategic Moves in Tech Investments

Updated Category News Views 340

Overview of ARK's Recent Trading Activity Cathie Wood's ARK ETFs are well-known for their assertive trading strategies, and the most recent report reveals their latest stock moves. The firm has made headlines again by announcing a series of buy and sell transactions that display its ongoing commitment to innovation and growth in the tech sector. Let's dive into the...

Continue Reading
NEWTON GOLF Unveils $1 Million Share Repurchase Initiative

Updated Category News Views 119

NEWTON GOLF Announces Share Repurchase Authorization CAMARILLO, CA -- NEWTON GOLF Company (Nasdaq: SPGC), a leading innovator in the golf industry, has announced an authorization for a share repurchase program amounting to $1 million. This decision reflects a robust strategy to leverage market conditions and enhance shareholder value. The repurchase program will commence...

Continue Reading
Veritone Class Action: Stakes High for Shareholders

Updated Category News Views 3

Veritone's Legal Turbulence: Class Action Looms Alright, folks, here we go—a class action's got Veritone, Inc. (NASDAQ: VERI) in hot water, and it's not looking pretty. Legal eagles over at Robbins LLP are spearheading this suit, claiming the AI company botched its financial reporting. If you're holding VERI shares from October 14, 2025, through April 14, 2026, listen...

Continue Reading
TimelyCare Excellently Recognized for Mental Health Support

Updated Category News Views 180

TimelyCare Receives Prestigious Award for Mental Health Advocacy TimelyCare, known as higher education's most trusted virtual health and well-being provider, is honored to be recognized in the "Best in Business" list by Inc. for its exceptional advocacy in mental health. A Commitment to Student Health and Wellness As a winner in the Mental Health Advocacy category,...

Continue Reading